WO1986004924A1 - Procede de preparation de n-formyl-l-peptides - Google Patents
Procede de preparation de n-formyl-l-peptides Download PDFInfo
- Publication number
- WO1986004924A1 WO1986004924A1 PCT/SU1986/000010 SU8600010W WO8604924A1 WO 1986004924 A1 WO1986004924 A1 WO 1986004924A1 SU 8600010 W SU8600010 W SU 8600010W WO 8604924 A1 WO8604924 A1 WO 8604924A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- synthesis
- acid
- αϊа
- mixture
- protected
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 38
- 108090000765 processed proteins & peptides Proteins 0.000 title description 4
- 102000004196 processed proteins & peptides Human genes 0.000 title description 2
- 150000001413 amino acids Chemical class 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims description 44
- 239000002253 acid Substances 0.000 claims description 27
- 230000008569 process Effects 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 9
- 150000007513 acids Chemical class 0.000 claims description 5
- 230000008901 benefit Effects 0.000 claims description 3
- -1 carboxyl compound Chemical class 0.000 abstract description 14
- 229910052751 metal Inorganic materials 0.000 abstract description 14
- 239000002184 metal Substances 0.000 abstract description 14
- 238000009833 condensation Methods 0.000 abstract description 4
- 230000005494 condensation Effects 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 3
- 108091005804 Peptidases Proteins 0.000 abstract description 2
- 102000035195 Peptidases Human genes 0.000 abstract description 2
- 235000019833 protease Nutrition 0.000 abstract description 2
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 abstract 1
- 241000193830 Bacillus <bacterium> Species 0.000 abstract 1
- VPZXBVLAVMBEQI-VKHMYHEASA-N Glycyl-alanine Chemical compound OC(=O)[C@H](C)NC(=O)CN VPZXBVLAVMBEQI-VKHMYHEASA-N 0.000 abstract 1
- DEFJQIDDEAULHB-IMJSIDKUSA-N L-alanyl-L-alanine Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(O)=O DEFJQIDDEAULHB-IMJSIDKUSA-N 0.000 abstract 1
- 108010079364 N-glycylalanine Proteins 0.000 abstract 1
- 108010056243 alanylalanine Proteins 0.000 abstract 1
- 108010047495 alanylglycine Proteins 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 abstract 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 description 47
- 238000003786 synthesis reaction Methods 0.000 description 46
- 239000000047 product Substances 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 16
- 229940024606 amino acid Drugs 0.000 description 16
- 229960005190 phenylalanine Drugs 0.000 description 16
- 235000001014 amino acid Nutrition 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- 150000001412 amines Chemical class 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 12
- 230000002378 acidificating effect Effects 0.000 description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 8
- 108090001109 Thermolysin Proteins 0.000 description 7
- 150000003931 anilides Chemical class 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000001540 azides Chemical class 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 125000006239 protecting group Chemical group 0.000 description 6
- 239000004471 Glycine Substances 0.000 description 5
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 150000004702 methyl esters Chemical class 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- 230000001681 protective effect Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229910021653 sulphate ion Inorganic materials 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 3
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 3
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- 206010057249 Phagocytosis Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229960004050 aminobenzoic acid Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 238000003339 best practice Methods 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XBBCKDLKPZMCKR-HNNXBMFYSA-N (2S)-2-(N-methylanilino)-3-phenylpropanoic acid Chemical compound C([C@H](N(C)C=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 XBBCKDLKPZMCKR-HNNXBMFYSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- ZAIZDXVMSSDZFA-QRPNPIFTSA-N (2s)-2-amino-3-phenylpropanoic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CC=CC=C1 ZAIZDXVMSSDZFA-QRPNPIFTSA-N 0.000 description 1
- XKZZNHPZEPVUQK-JEDNCBNOSA-N (2s)-2-amino-4-methylpentanoic acid;hydron;chloride Chemical compound Cl.CC(C)C[C@H](N)C(O)=O XKZZNHPZEPVUQK-JEDNCBNOSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- FWEOQOXTVHGIFQ-UHFFFAOYSA-N 8-anilinonaphthalene-1-sulfonic acid Chemical compound C=12C(S(=O)(=O)O)=CC=CC2=CC=CC=1NC1=CC=CC=C1 FWEOQOXTVHGIFQ-UHFFFAOYSA-N 0.000 description 1
- KKUKTXOBAWVSHC-UHFFFAOYSA-N Dimethylphosphate Chemical compound COP(O)(=O)OC KKUKTXOBAWVSHC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Natural products NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- LBSARGIQACMGDF-WBAXXEDZSA-N Phe-Ala-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 LBSARGIQACMGDF-WBAXXEDZSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000269781 Zoarcidae Species 0.000 description 1
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000006242 amine protecting group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 229940051881 anilide analgesics and antipyretics Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000035605 chemotaxis Effects 0.000 description 1
- 231100000196 chemotoxic Toxicity 0.000 description 1
- 230000002604 chemotoxic effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- MHYCRLGKOZWVEF-UHFFFAOYSA-N ethyl acetate;hydrate Chemical compound O.CCOC(C)=O MHYCRLGKOZWVEF-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 150000005204 hydroxybenzenes Chemical class 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- MBABOKRGFJTBAE-UHFFFAOYSA-N methyl methanesulfonate Chemical compound COS(C)(=O)=O MBABOKRGFJTBAE-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical class [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- KOOMFXGDLMRWSN-UHFFFAOYSA-N n-phenylnitrous amide Chemical compound O=NNC1=CC=CC=C1 KOOMFXGDLMRWSN-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 125000001639 phenylmethylene group Chemical group [H]C(=*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000029305 taxis Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06104—Dipeptides with the first amino acid being acidic
- C07K5/06113—Asp- or Asn-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Definitions
- a phylum in the molecule is a must, as it is the person responsible for the interaction of the process and the incidence of impaired receptors The same reactions stimulate and certain other functions of the cells, such as aggregation, the separation of enzymes, and the use of toxic drugs.
- omega-milleptides is the front-25 sixth parameter - umo-milaspartum, that is, methyl-omega-omega-ashilane.
- BACKGROUND OF THE INVENTION There are various approaches to the synthesis of milieu. ⁇ lassiches ⁇ imi me ⁇ dami- ⁇ e ⁇ idn ⁇ g ⁇ sin ⁇ eza yavlya- 30 yu ⁇ sya ⁇ a ⁇ b ⁇ diimidny "me ⁇ d smeshanny ⁇ angid ⁇ id ⁇ v or a ⁇ ivi ⁇ vanny ⁇ e ⁇ i ⁇ v.
- the synthesis of fuels that support the reaction with the azide method in the process of the processes of anilide syntheses is mild clay and
- the azide method allows you to receive optically pure antagonists, - 3 -
- the syntheses of anilide of phenyl-glycine and ethyl ester of ⁇ - / phenyl-enriched acids are described in a similar manner in the food chain. Therefore, it is difficult to talk about the availability of 5 azide-type equipment in the synthesis of friendly drugs. Otherwise, the azide method is two-stage, it will protect all additional functional groups with the following removal, which significantly complicates and improves the welfare.
- the process is delivered with a high output reaching 90, when the physical process is removed and the process is secured. / ⁇ zothea G., ⁇ ⁇ ⁇ . , ⁇ with kato ⁇ . , ⁇ ⁇ . , ⁇ -
- a cost-effective method of synthesizing an attribute is the use of quality-guarded damp for amine function of acid acid.
- the source of the acylating agent used to introduce such protective groups in this case, they use, for example, nitrous-benzyl-benzyl-benzyl, is
- ⁇ is used to use synthetic amino acids to receive the target product, it is useful
- the embodiment of the present invention is disposed of in that, as a part of the external-urban environment, a single-dimethylated medium is used.
- the methods of obtaining ⁇ -fomp-pepstidov represent a private fragment 20 active synthesis of drugs.
- An advantageous enzyme synthesis of the test connection is a high process and regioselective process.
- Use of the product as a part of biosynthesis at the stage of the preparation of the battery is free of charge and the device is in contact with the It does not require the primary protection of amino acids, which contain additional functional groups in large quantities of radicals. For example, taking into account the acidity of 30 acids, the compensation is only for a large group, since it is a big accident.
- a protective deactivation of an etheric type can be carried out by metal, - 9 - Ethyl, benzyl esters.
- amide type protecting groups amide, anilide, substituted anilides, in particular, nitric anilides, hydrazide and substituted hydrazides may be used. 5 Sections
- the predominantly metal kinase does not impose a slight restriction on the cost of the aminogens that are not in use.
- amino acid residues for example, alanyl-alanyl, alanyl-glycyl, glycyl-alanyl, glycyl-glycyl.
- thermolysin 35 are close to thermolysin and could be used in the treatment of the analogous thermolysin.
- ch ⁇ for ⁇ e ⁇ aniya ⁇ tsessa tseles ⁇ b ⁇ aznee vseg ⁇ is ⁇ lz ⁇ va ⁇ in ⁇ aches ⁇ ve is ⁇ dn ⁇ g ⁇ ⁇ a ⁇ b ⁇ siln ⁇ g ⁇ ⁇ m ⁇ nen ⁇ a ⁇ mil- 5 s ⁇ de ⁇ zhaschie ⁇ izv ⁇ dnye me ⁇ i ⁇ nina, ⁇ enilalanina, alanyl-alashna, as ⁇ a ⁇ agin ⁇ v ⁇ y ⁇ isl ⁇ y, and ⁇ aches ⁇ ve amin ⁇ m ⁇ nen ⁇ a- ⁇ -ni ⁇ anilidy ⁇ enilalashna and leucine or me ⁇ il ⁇ vy e ⁇ i ⁇ ⁇ eshlalashna.
- ⁇ ⁇ edlagaem ⁇ m s ⁇ s ⁇ be sin ⁇ eza ⁇ - ⁇ mil- s - ⁇ e ⁇ - ⁇ id ⁇ v vys ⁇ aya e ⁇ e ⁇ e ⁇ sele ⁇ ivn ⁇ s ⁇ ⁇ e ⁇ men ⁇ a is ⁇ lzuem ⁇ - g ⁇ on s ⁇ adii ⁇ b ⁇ az ⁇ vaniya ⁇ e ⁇ idn ⁇ y communication ga ⁇ an ⁇ i ⁇ ue ⁇ 5 ⁇ b ⁇ az ⁇ vanie ⁇ l ⁇ ichessh chis ⁇ g ⁇ ⁇ du ⁇ a, ⁇ ichem is ⁇ lyu- chae ⁇ sya ⁇ sn ⁇ vnaya l ⁇ b ⁇ chnaya ⁇ ea ⁇ odya, ⁇ g ⁇ ashchivayuschaya ⁇ i- Menenius ⁇ mil-amin ⁇ isl ⁇ in ⁇ el ⁇ idn ⁇ m synthesis - ⁇ ⁇ ⁇ rect ⁇ ⁇
- the quantity of the substance used in the reaction may vary in wide terms ⁇ “ ⁇ 0 to 10 * 10 mm per I mmole of the connected. ⁇ a ⁇ i- me ⁇ , ⁇ i sin ⁇ eze pi-sh ⁇ ashlida ⁇ mil-alanyl-alashl- ⁇ eshlalashna, umensheshe ⁇ liches ⁇ va ⁇ e ⁇ men ⁇ a d ⁇
- the reaction is in the water or gadget environment.
- As a distributor usually use dimethylamide.
- the content of it in a converted mixture is up to $ 50 and the complete separation of the source of amine and a large, commercially available mixture.
- the active mixture contains 0.63 mmol of phenylmethylene and categorized-nitroanilide of leucine in 0.6 ml of dimethylphosphamide and 2 ml of 0, which is 2 mg or more than 2 mg / ml. -9, 2.5 mg of 20 (63 mmol) of thermolysin; the mixture is kept for 2 hours at 20 ⁇ and spend the night in the refrigerator, empty the filter and wash the pump in type I. - 16 -
- Acidic composition Ra 1.99; Lb 1.01. Examples 11-14 cm and table 2.
- the inactive mixture contains I mmol of phenylalanilalashne and ⁇ -nitrous phenylanilide in 0.4 ml of dimethylphosphamide and 0.6 ml of Caustic acid 6.9 / solution of 25 mg of sodium chloride.
- the non-reactive mixture contains 0.5 ml of 1 * 10 ⁇ CaS ⁇ ⁇ . ⁇ 6.9.
- the organic mixture contains 0.5 mmol of phenylalashl alashna and phenylalanine d-nitrile, 0.2 ml of methyl dimethylamide and 0.3 ml of water ( ⁇ , 6.7), which eliminates 20 bushes. 37.5 mg / ml, 10 that is 20 nm of the solids content, lasts 24 hours at the indicated temperature, then processes the analogous example I.
- ku ⁇ name is compact per hour ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ... in%
- the active mixture contains the indicated quantities of amine and carboxylic acid, 0.2 ml of dimethylphamide, 0.3 ml of water with a pH of 6.7 and 20 milliliters of a mixture of 10 mm, and are processing similar example I.
- the mixture was 0 ⁇ 88.g (I mm ⁇ l) ⁇ mil-alanyl-alanine and 0.251 g (I mm ⁇ l) n-ni ⁇ anilida l 'eyschna ⁇ as ⁇ v ⁇ yayu ⁇ 15 I dime ⁇ il ⁇ mamida ml, 5 ml ⁇ ibavlyayu ⁇ ⁇ as ⁇ v ⁇ a 5 * 10 2 ⁇ SaS ⁇ ⁇ 6,8, ⁇ and ⁇ stirring. add 5 mg (133 nmol) of thermolysin, stand for 6 hours at 22 ° ⁇ , then spend the night in a cold place. Filter the precipitated plant, wash the filter in the same way as Example I, and dry it in 20 vacuum drying. ⁇ regulate 0.305 g (72.5)
- Acidic composition Ley 1.0; ⁇ ier 1.0.
- Example 29 Synthesis of methyl ether-methyl-alcohol-phenylalanine. 15 ⁇ 2, 1 g (10 mmol) of methylated phenylalachine is added to 0.66 g (4, 1 mmol) of phenylmethyl acid in 2.0 ml of water. After reconstitution of the original connected mixture, the resulting mixture is 6.6–6.8 plus 6 N of the process mixture. Then, the 20 sample is dispensed with 20 mg (530 nm) of thermolysine and mixed on a magnetic stirrer for 24 hours at 25 ° ⁇ . The extract is dissolved in 25 ml of I ⁇ acetic acid and is treated with 30 ml
- Shchzhmeru 30 The synthesis of methyl ether-methyl-alcohol-feshlalashna. The synthesis of analogous example 29, proceeding from 35 2 mm of hydrochloric acid methyl phenylalachne and I mmol of acid-acid.
- the plant grows and grows. - 20 - in 4.5 ml of acetic acid, dilute the solution with a solution of 40 ml of ethyl acetate, remove the precipitated salt, wash the solution with water and let the solution dry. K ⁇ k ⁇ d 5 0, 140 mg ($ 43). Pshmera 31.
- a mixture of 0.376 g (2 mmol) of I-phyrmethyl-alanyl-alanine Yu and 0.430 g (2 mmol) of hydrochloride solution is suitable: alanine is dissolved in 0.5 ml of a non-corrosive mixture, but 6.7, 3 mg of metal acetate is introduced; Acetic acid Acetate is stirred for 24 hours at 25 ° £ .0 Garden is dissolved in ethyl 15 acetate and is replaced with water; The organic layer is dried over the sulphate of the country, then evaporated in a vacuum. Food product 0.25 g (32); ⁇ £ -_ 0.71.
- Acidic composition Ra 1.98; Ley 1.02. Example 33.
- Example 35 The synthesis of ⁇ -strained schlide ⁇ -promyl-phenylalashne and 29 mg (100 ⁇ mol) of ⁇ -nitroanilide phenylalachine was diluted in 0.2 ml of dimethylsulfonate and diluted with a small amount of 8 ml. Introduces 0.5 mg of the metalase kinase ⁇ as ⁇ iz al-u ⁇ o ⁇ i ⁇ as ⁇ and excrete 24 hours at 25 ° 0. The product is processed in a similar manner to Example 33. The yield of the product is 35.5 mg (76).
- Acidic composition ⁇ 0.98; 1,0 ⁇ lingually 0.99; 1,0 ⁇ lingually 0.99; 1,0 ⁇ lingually 0.03.
- Example 39 There is a similar procedure to Example 36 except that the active mixture is left at 2 ° C for 72 hours. ⁇ Play 0, 230 g ($ 18).
- Example 39 •
- Example 36 There is a similar procedure to Example 36, except that the active mixture leaves at 60 ° C for 24 hours. Food product 0, 14 g ($ 11).
- 20 types are an attribute of an attribute - for mililaspa- tam, that is, methyl ether-free-phenylalanal.
- the equipment is about 200 times good for sweeteners and can be used
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Des N-formyl-L-peptides de formule générale (I) sont obtenus par condensation d'un composé carboxyle N-formyl-protégé de formule générale (II) avec un acide aminé présentant une protection sur le groupe carboxyle et une formule générale (III) en présence de la métalloprotéinase produite par un micro-organisme de genre Bacillus. La condensation est effectuée dans un milieu aqueux ou aqueux-organique, à un pH compris entre 6,0 et 9,0 et à une température comprise entre 0 et 60oC. For -A-B-X (I), For -A-OH (II), H-B-X (III), où For - formyl; A - Asp, Met, Gly, Ala, Gly-Gly, Gly-Ala, Ala-Gly, Ala-Ala, Tyr, Phe; B - Phe, Leu, Ile, Val; X - -OCH3 -OC2H5; -OCH2C6H5; -NH2; -NH-C6H5; -p-NH-C6H4-NO2 -NH-NH2; -NH-NH-C6H5.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19863690076 DE3690076T1 (fr) | 1985-02-15 | 1986-02-13 | |
NL8620072A NL8620072A (nl) | 1985-02-15 | 1986-02-13 | Werkwijze voor de bereiding van n-formyl-l-peptiden. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU3855631 | 1985-02-15 | ||
SU3855631/23 | 1985-02-15 | ||
SU4014768 | 1986-02-10 | ||
SU4014768/28 | 1986-02-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1986004924A1 true WO1986004924A1 (fr) | 1986-08-28 |
Family
ID=26666020
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SU1986/000010 WO1986004924A1 (fr) | 1985-02-15 | 1986-02-13 | Procede de preparation de n-formyl-l-peptides |
Country Status (3)
Country | Link |
---|---|
DE (1) | DE3690076T1 (fr) |
NL (1) | NL8620072A (fr) |
WO (1) | WO1986004924A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016546A1 (fr) * | 1996-10-15 | 1998-04-23 | Holland Sweetener Company V.O.F. | METHODE ENZYMATIQUE POUR PRODUIRE DU N-FORMYL-α-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ220958A (en) * | 1986-12-22 | 1989-08-29 | Grace W R & Co | Enzymatic production of peptides in water-miscible organic solvents |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4116768A (en) * | 1975-04-29 | 1978-09-26 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US4119493A (en) * | 1975-10-23 | 1978-10-10 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US4284721A (en) * | 1979-04-03 | 1981-08-18 | Sagami Chemical Research Center | Method for manufacturing dipeptides |
DE3203292A1 (de) * | 1981-02-02 | 1982-09-16 | G.D. Searle & Co., 60076 Skokie, Ill. | Verfahren zur herstellung von aminogeschuetzten l-aspartyl-l-phenylalanin-alkylestern |
EP0149594A2 (fr) * | 1984-01-16 | 1985-07-24 | Monsanto Company | Accouplement enzymatique de N-formyl amino-acides et/ou de restes peptidiques |
CH651067A5 (de) * | 1980-09-02 | 1985-08-30 | Searle & Co | Verfahren zum verestern von alpha-l-aspartyl-l-phenylalanin. |
-
1986
- 1986-02-13 DE DE19863690076 patent/DE3690076T1/de not_active Withdrawn
- 1986-02-13 WO PCT/SU1986/000010 patent/WO1986004924A1/fr unknown
- 1986-02-13 NL NL8620072A patent/NL8620072A/nl unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4116768A (en) * | 1975-04-29 | 1978-09-26 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US4119493A (en) * | 1975-10-23 | 1978-10-10 | (Zaidanhojin) Sagami Chemical Research Center | Process for producing a peptide |
US4284721A (en) * | 1979-04-03 | 1981-08-18 | Sagami Chemical Research Center | Method for manufacturing dipeptides |
CH651067A5 (de) * | 1980-09-02 | 1985-08-30 | Searle & Co | Verfahren zum verestern von alpha-l-aspartyl-l-phenylalanin. |
DE3203292A1 (de) * | 1981-02-02 | 1982-09-16 | G.D. Searle & Co., 60076 Skokie, Ill. | Verfahren zur herstellung von aminogeschuetzten l-aspartyl-l-phenylalanin-alkylestern |
EP0149594A2 (fr) * | 1984-01-16 | 1985-07-24 | Monsanto Company | Accouplement enzymatique de N-formyl amino-acides et/ou de restes peptidiques |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016546A1 (fr) * | 1996-10-15 | 1998-04-23 | Holland Sweetener Company V.O.F. | METHODE ENZYMATIQUE POUR PRODUIRE DU N-FORMYL-α-L-ASPARTYL-L-PHENYLALANINE METHYL ESTER |
Also Published As
Publication number | Publication date |
---|---|
DE3690076T1 (fr) | 1987-03-12 |
NL8620072A (nl) | 1986-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zahler et al. | Distinct functions of SR proteins in alternative pre-mRNA splicing | |
Hauschka et al. | Calcium-dependent. alpha.-helical structure in osteocalcin | |
WO1988008453A1 (fr) | Procede pour obtenir des polypeptides dans un systeme de translation acellulaire | |
ES2701727T3 (es) | Uso de beta-dipéptidos de cianoficina | |
Folk et al. | Chromogenic leucyl substrates for aminopeptidase and papain | |
JPS60152500A (ja) | α−アミラ−ゼ抑制作用を有する新規ポリペプチドおよびそれらの製法 | |
JP3488722B2 (ja) | カルシウム吸収促進活性剤及びその製造法 | |
Vernon | Pyrularia thionin: physical properties, biological responses and comparison to other thionins and cardiotoxin | |
EP2091553B1 (fr) | Peptides derives de la caseine ayant une activité anxiolytique | |
WO1986004924A1 (fr) | Procede de preparation de n-formyl-l-peptides | |
Wiggans et al. | Action of cathepsin C on dipeptide esters | |
Hishizawa et al. | Studies on the formation of transfer ribonucleic acid-ribosome complexes: XVII. The effect of tRNA on aminoacyl-oligonucleotide binding to ribosomes | |
DK154434B (da) | Analogifremgangsmaade til fremstilling af tripeptidderivater | |
Kato et al. | Studies on substrate specificity of X-prolyl dipeptidyl-aminopeptidase using new chromogenic substrates, XYp-nitroanilides | |
Rothman | Role of bile salts in the biology of tapeworms. I. Effects on the metabolism of Hymenolepis diminuta and Oochoristica symmetrica | |
CN114032271B (zh) | 具有降尿酸功效的牡蛎多肽、多肽粉及制备方法和应用 | |
Brown et al. | On the deaminating enzyme of flesh-fly larvae | |
JPH0279990A (ja) | ホスファチジルセリンの製造方法 | |
WO2002024610A2 (fr) | Procede de production d'un antineoplasique | |
WO2002044352A1 (fr) | Complexe bacteriolytique, procede de fabrication et souche destinee a mettre en oeuvre ce procede | |
WO1996019999A1 (fr) | Enzyme thrombolytique et son procede d'obtention | |
FR2476128A1 (fr) | Procede microbiologique de production de narasine et cultures contenant le microorganisme producteur streptomyces lydicus deboer et al- | |
JP3056543B2 (ja) | 新規ペプチド | |
WO1995023783A1 (fr) | Cetopanthenol presentant des proprietes acetylantes | |
CA2123587A1 (fr) | Produit bactericide, composition pharmaceutique le contenant et additif alimentaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): DE JP NL US |